title: Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.
abstract: Squamous cell carcinoma of the head and neck region (HNSCC), which is related to an infection with human papilloma virus (HPV), responds better to simultaneous radio-chemotherapy with Cisplatin based regimens than HPV-negative tumors. The underlying molecular mechanisms for this clinical observation are not fully understood. Therefore, the response of four HPV-positive (HPV+) (UM-SCC-47, UM-SCC-104, 93-VU-147T, UPCI:SCC152) and four HPV-negative (HPV-) (UD-SCC-1, UM-SCC-6, UM-SCC-11b, UT-SCC-33) HNSCC cell lines to x-irradiation ± Cisplatin incubation in terms of clonogenic survival, cell cycle progression, protein expression (cyclin A2, cyclin E2, E6, E7, p53) and induction of apoptosis, was investigated. HPV+ cells were more radio- and chemosensitive and were more effectively sensitized to x-irradiation by simultaneous Cisplatin incubation than HPV- cell lines. HPV+ cell lines revealed an increased and prolonged G2/M arrest after irradiation, whereas Cisplatin induced a blockage of cells in S phase. In comparison to irradiation only, addition of Cisplatin significantly enhanced apoptosis especially in HPV+ cell lines. While irradiation alone increased the amount of HPV E6 and E7 proteins, both were down-regulated by Cisplatin incubation either alone or in combination with x-rays, which however did not increase the expression of endogenous p53. Our results demonstrate that cell cycle deregulation together with downregulation of HPV E6 and E7 proteins facilitating apoptosis after Cisplatin incubation promote the enhanced sensitivity of HPV+ HNSCC cells to simultaneous radio-chemotherapy. Combined effects of irradiation and Cisplatin appear to be relevant in mediating the enhanced therapeutic response of HPV-related HNSCC and are indicative of the benefit of combined modality approaches in future treatment optimization strategies.
authors.affiliation: Department of Radiotherapy and Radiooncology, Philipps-University, University Hospital Gießen and Marburg Marburg, Germany.
authors.forename: Frank
authors.initials: F
authors.lastname: Ziemann
authors.affiliation: Department of Radiotherapy and Radiooncology, Philipps-University, University Hospital Gießen and Marburg Marburg, Germany.
authors.forename: Andrea
authors.initials: A
authors.lastname: Arenz
authors.affiliation: Department of Radiotherapy and Radiooncology, Philipps-University, University Hospital Gießen and Marburg Marburg, Germany.
authors.forename: Stefanie
authors.initials: S
authors.lastname: Preising
authors.affiliation: Department of Otorhinolaryngology and Head and Neck Surgery, Justus Liebig University, University Hospital Gießen and Marburg Giessen, Germany.
authors.forename: Claus
authors.initials: C
authors.lastname: Wittekindt
authors.affiliation: Department of Otorhinolaryngology and Head and Neck Surgery, Justus Liebig University, University Hospital Gießen and Marburg Giessen, Germany.
authors.forename: Jens P
authors.initials: JP
authors.lastname: Klussmann
authors.affiliation: Department of Radiotherapy and Radiooncology, Philipps-University, University Hospital Gießen and Marburg Marburg, Germany.
authors.forename: Rita
authors.initials: R
authors.lastname: Engenhart-Cabillic
authors.affiliation: Department of Radiotherapy and Radiooncology, Philipps-University, University Hospital Gießen and Marburg Marburg, Germany.
authors.forename: Andrea
authors.initials: A
authors.lastname: Wittig
keywords: HPV E6/E7 protein; Head and neck cancer; apoptosis; p53; radio-chemotherapy